ID

35602

Descrizione

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02493205

collegamento

https://clinicaltrials.gov/show/NCT02493205

Keywords

versioni (1)
  1. 11/03/19 11/03/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

11 marzo 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Coronary Artery Disease NCT02493205

Inglese

Eligibility Coronary Artery Disease NCT02493205

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patient is indicated for continuous arrhythmia monitoring with an implantable cardiac monitor
Descrizione

Indication Cardiac Arrhythmia Monitoring | Cardiac monitor Implantable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0003811
UMLS CUI [1,3]
C0150369
UMLS CUI [2,1]
C0179608
UMLS CUI [2,2]
C0021102
2. patient is willing to undergo implant in holding area setting with only local anesthetic and/or oral anti-anxiety medications for sedation (2 mg of valium or ativan) at patient request.
Descrizione

Implantation Willing | Local Anesthetic | Anti-Anxiety Agents Oral | Valium | Ativan

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021107
UMLS CUI [1,2]
C0600109
UMLS CUI [2]
C0002934
UMLS CUI [3,1]
C0040616
UMLS CUI [3,2]
C1527415
UMLS CUI [4]
C0699187
UMLS CUI [5]
C0699194
3. patient is 18 years of age or older.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
4. patient is willing to provide informed consent and authorize disclosure of personal health information in accordance with state and national regulations.
Descrizione

Informed Consent | Health information Disclosure authorized by Patient

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0850397
UMLS CUI [2,2]
C0012625
UMLS CUI [2,3]
C1551374
UMLS CUI [2,4]
C0030705
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patient has reduced immune function or is otherwise at high risk for infection
Descrizione

Immune function Reduced | High risk of Communicable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1817756
UMLS CUI [1,2]
C0392756
UMLS CUI [2,1]
C0332167
UMLS CUI [2,2]
C0009450
2. patient has had a recent (within 30 days) or otherwise unresolved infection.
Descrizione

Communicable Disease | Resolution Lacking Communicable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C1514893
UMLS CUI [2,2]
C0332268
UMLS CUI [2,3]
C0009450
3. patient is implanted or indicated for implant with a pacemaker, implantable cardiac device (icd), cardiac resyncronization therapy (crt) or hemodynamic monitoring system.
Descrizione

Pacemaker implant | Indication Pacemaker implant | Implantable defibrillator | Indication Implantable defibrillator | Cardiac Resynchronization Therapy | Indication Cardiac Resynchronization Therapy | Hemodynamic Monitoring System | Indication Hemodynamic Monitoring System

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0848753
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C0848753
UMLS CUI [3]
C0162589
UMLS CUI [4,1]
C3146298
UMLS CUI [4,2]
C0162589
UMLS CUI [5]
C1167956
UMLS CUI [6,1]
C3146298
UMLS CUI [6,2]
C1167956
UMLS CUI [7]
C4287143
UMLS CUI [8,1]
C3146298
UMLS CUI [8,2]
C4287143
4. patient is participating in another clinical trial that may have an impact on the trial endpoints.
Descrizione

Study Subject Participation Status Impact End Point

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C4049986
UMLS CUI [1,3]
C2349179
5. patient has a super-therapeutic inr > 3.0.
Descrizione

Supratherapeutic INR

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4049341
6. patient considered by principal investigator and/or sub-investigator to be inappropriate for the trial for any reason.
Descrizione

Study Subject Participation Status Inappropriate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548788
7. patient's life expectancy is less than 1 year.
Descrizione

Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
8. patient is pregnant.
Descrizione

Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
9. patient has an unusual thoracic anatomy or scarring at the implant site which may adversely affect the success of the implant procedure.
Descrizione

Anatomic structure thoracic Unusual | Cicatrization Implant Site | At risk Implantation procedure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0700276
UMLS CUI [1,2]
C0817096
UMLS CUI [1,3]
C2700116
UMLS CUI [2,1]
C0008767
UMLS CUI [2,2]
C0021102
UMLS CUI [2,3]
C1515974
UMLS CUI [3,1]
C1444641
UMLS CUI [3,2]
C0021107
10. inability to comply with planned trial procedures
Descrizione

Protocol Compliance Unable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
Ritorna all'inizio della pagina

Similar models

Eligibility Coronary Artery Disease NCT02493205

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Indication Cardiac Arrhythmia Monitoring | Cardiac monitor Implantable
Item
1. patient is indicated for continuous arrhythmia monitoring with an implantable cardiac monitor
boolean
C3146298 (UMLS CUI [1,1])
C0003811 (UMLS CUI [1,2])
C0150369 (UMLS CUI [1,3])
C0179608 (UMLS CUI [2,1])
C0021102 (UMLS CUI [2,2])
Implantation Willing | Local Anesthetic | Anti-Anxiety Agents Oral | Valium | Ativan
Item
2. patient is willing to undergo implant in holding area setting with only local anesthetic and/or oral anti-anxiety medications for sedation (2 mg of valium or ativan) at patient request.
boolean
C0021107 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0002934 (UMLS CUI [2])
C0040616 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0699187 (UMLS CUI [4])
C0699194 (UMLS CUI [5])
Age
Item
3. patient is 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Informed Consent | Health information Disclosure authorized by Patient
Item
4. patient is willing to provide informed consent and authorize disclosure of personal health information in accordance with state and national regulations.
boolean
C0021430 (UMLS CUI [1])
C0850397 (UMLS CUI [2,1])
C0012625 (UMLS CUI [2,2])
C1551374 (UMLS CUI [2,3])
C0030705 (UMLS CUI [2,4])
Item Group
C0680251 (UMLS CUI)
Immune function Reduced | High risk of Communicable Disease
Item
1. patient has reduced immune function or is otherwise at high risk for infection
boolean
C1817756 (UMLS CUI [1,1])
C0392756 (UMLS CUI [1,2])
C0332167 (UMLS CUI [2,1])
C0009450 (UMLS CUI [2,2])
Communicable Disease | Resolution Lacking Communicable Disease
Item
2. patient has had a recent (within 30 days) or otherwise unresolved infection.
boolean
C0009450 (UMLS CUI [1])
C1514893 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
Pacemaker implant | Indication Pacemaker implant | Implantable defibrillator | Indication Implantable defibrillator | Cardiac Resynchronization Therapy | Indication Cardiac Resynchronization Therapy | Hemodynamic Monitoring System | Indication Hemodynamic Monitoring System
Item
3. patient is implanted or indicated for implant with a pacemaker, implantable cardiac device (icd), cardiac resyncronization therapy (crt) or hemodynamic monitoring system.
boolean
C0848753 (UMLS CUI [1])
C3146298 (UMLS CUI [2,1])
C0848753 (UMLS CUI [2,2])
C0162589 (UMLS CUI [3])
C3146298 (UMLS CUI [4,1])
C0162589 (UMLS CUI [4,2])
C1167956 (UMLS CUI [5])
C3146298 (UMLS CUI [6,1])
C1167956 (UMLS CUI [6,2])
C4287143 (UMLS CUI [7])
C3146298 (UMLS CUI [8,1])
C4287143 (UMLS CUI [8,2])
Study Subject Participation Status Impact End Point
Item
4. patient is participating in another clinical trial that may have an impact on the trial endpoints.
boolean
C2348568 (UMLS CUI [1,1])
C4049986 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
Supratherapeutic INR
Item
5. patient has a super-therapeutic inr > 3.0.
boolean
C4049341 (UMLS CUI [1])
Study Subject Participation Status Inappropriate
Item
6. patient considered by principal investigator and/or sub-investigator to be inappropriate for the trial for any reason.
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Life Expectancy
Item
7. patient's life expectancy is less than 1 year.
boolean
C0023671 (UMLS CUI [1])
Pregnancy
Item
8. patient is pregnant.
boolean
C0032961 (UMLS CUI [1])
Anatomic structure thoracic Unusual | Cicatrization Implant Site | At risk Implantation procedure
Item
9. patient has an unusual thoracic anatomy or scarring at the implant site which may adversely affect the success of the implant procedure.
boolean
C0700276 (UMLS CUI [1,1])
C0817096 (UMLS CUI [1,2])
C2700116 (UMLS CUI [1,3])
C0008767 (UMLS CUI [2,1])
C0021102 (UMLS CUI [2,2])
C1515974 (UMLS CUI [2,3])
C1444641 (UMLS CUI [3,1])
C0021107 (UMLS CUI [3,2])
Protocol Compliance Unable
Item
10. inability to comply with planned trial procedures
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial